Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Lymphoma

MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies

Abstract

MUM1/IRF4 is a myeloma-associated oncogene transcriptionally activated as a result of t(6;14)(p25,q32) chromosomal translocation and by virtue of its juxtaposition to the immunoglobulin heavy chain gene (IgH) locus. When this oncogene becomes non-functional, no activated B/T lymphocytes and Ig secreting plasma cells are observed, suggesting that MUM1/IRF4 is crucial for lymphoid development. Its expression was analyzed in both reactive lymphoid and lymphoma tissues by means of an immunohistochemical technique using specific goat antiserum against MUM1/IRF4. This analysis detected a 50 kDa MUM1product whose localization was restricted to the nuclei of the lymphocytes. The MUM1+ cells in reactive lymph nodes were found to consist of plasma cells and a small fraction (approximately 7.9%) of B cells harboring CD20+CD38+, which were located in the light zone of the germinal center. MUM1 expression in peripheral blood B/T lymphocytes was upregulated by mitogenic stimuli, suggesting that MUM1 positivity represents the activated state of the B/T cells. In B cell non-Hodgkin's lymphoma (NHL), MUM1 expression was observed in 73.2% (30/41) of diffuse large B cell lymphoma (DLBCL), 20% (1/5) of marginal zone lymphoma (MZL) and 43% (3/7) of small lymphocytic lymphoma (SLL) cases, whereas it was not seen in any cases of mantle cell lymphoma (MCL) or follicle center lymphoma (FCL). Also, MUM1 was stained at high intensity in various types of T cell lymphomas including adult T cell leukemia/lymphoma (ATL/L) and anaplastic large cell lymphoma (ALCL) and in the majority of Hodgkin's diseases. Our results suggest that a major proportion of lymphomas comprise either physiologically or aberrantly activated neoplastic lymphocytes expressing the MUM1 protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK, Dalla-Favera R . Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma Nat Genet 1997 17: 226–230

    Article  CAS  PubMed  Google Scholar 

  2. Taniguchi T, Harada H, Lamphier M . Regulation of the interferon system and cell growth by the IRF transcription factors J Cancer Res Clin Oncol 1995 121: 516–520

    Article  CAS  PubMed  Google Scholar 

  3. Harada H, Taniguchi T, Tanaka N . The role of interferon regulatory factors in the interferon system and cell growth control Biochimie 1998 80: 641–650

    Article  CAS  PubMed  Google Scholar 

  4. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes BJ, O'Connell E, Hu-Li J, Paul WE, Jankovic D, Sher AF, Coligan JE, Thornton A, Appella E, Yang Y, Ozato K . Expression of IFN regulatory factor family proteins in lymphocytes J Immunol 1996 156: 3711–3720

    CAS  PubMed  Google Scholar 

  5. Matsuyama T, Grossman A, Mittrücker H-W, Siderovski DP, Kiefer F, Kawakami T, Richardson CD, Taniguchi T, Yoshinaga SK, Mak TW . Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE) Nucleic Acids Res 1995 23: 2127–2136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Yamagata T, Nishida J, Tanaka T, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H . A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes Mol Cell Biol 1996 16: 1283–1294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Grossman A, Mittrücker H-W, Nicholl J, Suzuki A, Chung S, Antonio L, Suggs S, Sutherland GR, Siderovski DP, Mak TW . Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-p25 Genomics 1996 37: 229–233

    Article  CAS  PubMed  Google Scholar 

  8. Eisenbeis C, Singh H, Storb U . Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator Genes Dev 1995 9: 1377–1387

    Article  CAS  PubMed  Google Scholar 

  9. Pongubala JMR, Atchison ML . PU.1 can participate in an active enhancer complex without its transcriptional activation domain Proc Natl Acad Sci USA 1997 94: 127–132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yee AA, Yin P, Siderovski DP, Mak TW, Litchfield DW, Arrowsmith CH . Cooperative interaction between the DNA-binding domains of PU.1 and IRF4 J Mol Biol 1998 279: 1075–1083

    Article  CAS  PubMed  Google Scholar 

  11. Brass AL, Zhu AQ, Singh H . Assembly requirements of PU.1-Pip (IRF4) activator complexes: inhibiting function in vivo using fused dimers EMBO J 1999 18: 977–991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mittrücker H-W, Matsuyama T, Grossman A, Kündig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW . Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function Science 1997 275: 540–543

    Article  PubMed  Google Scholar 

  13. Iida S, Seto M, Yamamoto K, Komatsu H, Tojo A, Asano S, Kamada N, Ariyoshi Y, Takahashi T, Ueda R . MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13 Oncogene 1993 8: 3085–3092

    CAS  PubMed  Google Scholar 

  14. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, Wolf-Peeters CD, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfliaer E, Warnke RA . A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361–1392

    CAS  PubMed  Google Scholar 

  15. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y . The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining Am J Pathol 1986 125: 431–435

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Glimcher LH, Singh H . Transcription factors in lymphocyte development-T and B cells get together Cell 1999 96: 13–23

    Article  CAS  PubMed  Google Scholar 

  17. Cattoretti G, Chang C-C, Cechova K, Zhang J, Ye B, Falini B, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R . BCL-6 protein is expressed in germinal-center B cells Blood 1995 86: 45–53

    CAS  PubMed  Google Scholar 

  18. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ . BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death Proc Natl Acad Sci USA 1991 88: 6961–6965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M . Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphoma Blood 1998 92: 1308–1316

    CAS  PubMed  Google Scholar 

  20. Yoshida S, Nakazawa N, Iida S, Hayami Y, Sato S, Wakita A, Shimizu S, Taniwaki M, Ueda R . Detection of MUM1/IRF4-IgH fusion in multiple myeloma Leukemia 1999 13: 1812–1816

    Article  CAS  PubMed  Google Scholar 

  21. Efremov DG, Ivanovski M, Batista FD, Pozzato G, Burrone OR . IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations J Clin Invest 1996 98: 290–298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Matolcsy A, Casali P, Nador RG, Liu YF, Knowles DM . Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells Blood 1997 89: 1732–1739

    CAS  PubMed  Google Scholar 

  23. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N . IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 1999 94: 1840–1847

    CAS  PubMed  Google Scholar 

  24. Naylor M, Carpa JD . Mutational status of IgVH genes provides clinically valuable information in B-cell chronic lymphocytic leukemia Blood 1999 94: 1837–1839

    CAS  PubMed  Google Scholar 

  25. Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He W-W, Ricciardi-Castagnoli P, Rosen CA, Carter KC . Reed–Sternberg cell genome expression supports a B-cell lineage Blood 1999 94: 411–416

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Mss C Fukuyama, K Sanuki and E Tochizawa for their skillful technical assistance, and K Okumura for her secretarial work. This work was supported in part by Grants-in-Aid for S Iida and R Ueda from the Ministry of Education, Science and Culture and for R Ueda from the Ministry of Health and Welfare, Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsuboi, K., Iida, S., Inagaki, H. et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 14, 449–456 (2000). https://doi.org/10.1038/sj.leu.2401696

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401696

Keywords

This article is cited by

Search

Quick links